Since November 2014, Rasi has served as principal adviser in charge of strategy following the judgment of the E.U. Civil Service Tribunal that annulled in part the 2011 selection procedure for the position of executive director of the EMA. From November 2011 to November 2014, he was the executive director of the EMA and a member of its management board.
Rasi was director-general of the Italian Medicines Agency from 2008 to 2011 and a member of the management board from 2004 and 2008. He was made full professor of microbiology at the University of Rome “Tor Vergata” in 2008.
From 2005 to 2008, he was director of the Institute of Molecular Medicine of the National Research Council in Rome. Rasi also worked at the Institute for Experimental Medicine of the National Research Council, Italy, and has previous teaching and research experience at the University of California, Berkeley.
Deputy Executive Director Andreas Pott will continue to lead EMA operations and to legally represent the agency until the new executive director has officially taken up his duties.